Clinical Trial Update: Rejuvesol® Washed RBC in Sickle Cell Patients Requiring Frequent Transfusions [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the use of Rejuvesol-washed red blood cells in sickle cell patients who require frequent transfusions; results have bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Rejuvesol Washed RBC

Snippet

Sponsor: Duke University | Conditions: Sickle Cell Disease | Phase 4 | Status: COMPLETED | Results posted: 2019-01-25